{"id":"tp-49748","type":"article-newspaper","title":"McKesson Is Closing a $2.25 Billion Precision Medicine Group Deal","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/49748","datePublished":"2026-11-06T02:47:11.000Z","dateModified":"2026-11-06T02:47:11.000Z","language":"en","abstract":"The deal comes as McKesson’s fiscal 2027 adjusted earnings outlook stands at $45.60 to $46.40 per diluted share.","section":"Business","references":[{"title":"fiscal 2027 adjusted earnings per diluted share outlook","url":"https://www.tokenpost.com/news/business/49565"}]}